<DOC>
	<DOC>NCT02442271</DOC>
	<brief_summary>This is a Phase 3b, open-label, multicenter study to evaluate the proportion of subjects achieving sustained virologic response 12 weeks post-treatment (SVR12), in adults with genotype 1 (GT1) chronic HCV infection, who received treatment with ombitasvir/paritaprevir/ritonavir and dasabuvir with or without ribavirin.</brief_summary>
	<brief_title>A Study to Evaluate the Efficacy and Safety of Three Experimental Drugs in Adults With Hepatitis C Virus Infection, Who Are Either Treatment-naive or Treatment-experienced in Brazil</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis, Chronic</mesh_term>
	<mesh_term>Hepatitis C, Chronic</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<criteria>Females must be postmenopausal for more than 2 years or surgically sterile or practicing acceptable forms of birth control Males must be surgically sterile or agree to practice acceptable forms of birth control Chronic hepatitis C at screening Fibrosis stage F3 or greater, documented by acceptable tests Participants with cirrhosis: Absence of hepatocellular carcinoma (HCC) as indicated by acceptable methods Women who are pregnant or breastfeeding Positive test result for Hepatitis B surface antigen (HbsAg) or antiHIV antibody positive (HIV Ab) Use of contraindicated medications within 2 weeks of dosing Clinically significant abnormalities or comorbidities History of solid organ transplant Abnormal laboratory tests Current or past clinical evidence of ChildPugh B or C classification or clinical history of liver decompensation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Chronic Hepatitis C</keyword>
	<keyword>Hepatitis C Treatment Naive</keyword>
	<keyword>Hepatitis C Genotype 1</keyword>
	<keyword>Hepatitis C Treatment Experienced</keyword>
	<keyword>Hepatitis C Virus</keyword>
</DOC>